Evidence map›Paper›PMID 37087494›Full record

ArticleCommunications biology2023

Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse model.

A K Patel, Ankur Dhanik, Wei Keat Lim, Christina Adler, Min Ni, Yi Wei, Maggie Zhong, Cindy Nguyen, Jun Zhong, Yi-Fen Lu and 5 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

A K PatelRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.
Ankur DhanikGritstone Bio, 40 Erie St., Cambridge, MA, 02139, USA.
Wei Keat LimRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.ORCID 0000-0002-6226-2570
Christina AdlerRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.
Min NiRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.ORCID 0000-0001-6382-0848
Yi WeiRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.
Maggie ZhongRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.ORCID 0000-0003-4632-7909
Cindy NguyenEli Lilly and Company, 450 E 29th St., New York, NY, 10016, USA.
Jun ZhongRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.
Yi-Fen LuRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.ORCID 0000-0002-4066-2557
Gavin ThurstonRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.
Lynn MacdonaldRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.
Andrew MurphyRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA.ORCID 0000-0003-4152-4081
Cagan GurerTScan Therapuetics, 830 Winter St., Waltham, MA, 02451, USA.
Davor FrletaRegeneron Pharmaceuticals, Inc., 795 Old Saw Mill River River Road Tarrytown, Tarrytown, NY, 10591, USA. davor.frleta@regeneron.com.ORCID 0000-0003-1295-0022
Regeneron (United States) · USEli Lilly (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunodeficient mice reconstituted with a human immune system (HIS mice) give rise to human T cells, which make them an attractive system to study human immune responses to tumors. However, such HIS mice typically exhibit sub-optimal responses to immune challenges as well as fail to develop antigen-specific B or T cell memory. Here we report HIS mice mediate spontaneous regression of human B cell lymphoma Raji. Tumor regression was dependent on CD4+ and CD8+ T cell responses and resulted in T cell memory. The T cell memory elicited was mainly Raji-specific, however some level of cross-protection was also elicited to a related B cell lymphoma cell line Ramos. Single-cell RNAseq analysis indicated activation of CD8+ T cells in regressing Raji tumors as well as clonal expansion of specific T cell receptors (TCRs). Cloning of TCRs from Raji-infiltrating T cells into a Jurkat reporter cell line showed reactivity specific for Raji tumor cells. Overall, we report a platform for studying in vivo human T cell tumor immunity by highlighting spontaneous Raji tumor regression, clonal TCR expansion, and T cell memory in HIS mice.

Indexed as

CD8-Positive T-LymphocytesLymphoma, B-CellAnimalsHumansJurkat CellsMiceReceptors, Antigen, T-CellReceptors, Antigen, T-Cell

Identifiers

PMID37087494
PMCPMC10122651
OpenAlexW4366770019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.